肺癌患者-话题@MedSci

#肺癌患者#

303篇内容 | 5545人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1990736, encodeId=db821990e3633, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=J Clin Oncol：转移性鳞状非小细胞肺癌患者中使用卡铂-紫杉醇联合培博利珠单抗可改善患者的生活质量, objectType=article, longId=199699, objectId=d1b8199699d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1b8199699d0, replyNumber=0, likeNumber=71, createdTime=2020-10-05, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1b8199699d0, moduleTitle=J Clin Oncol：转移性鳞状非小细胞肺癌患者中使用卡铂-紫杉醇联合培博利珠单抗可改善患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1b8199699d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990731, encodeId=7e9c1990e31f3, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Clini Cancer Res：SMARCA4突变可预测肺癌患者预后, objectType=article, longId=198071, objectId=4b131980e104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b131980e104, replyNumber=0, likeNumber=86, createdTime=2021-06-22, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b131980e104, moduleTitle=Clini Cancer Res：SMARCA4突变可预测肺癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b131980e104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990709, encodeId=7ed81990e09e4, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=欧盟批准武田的TKI抑制剂ALUNBRIG，用作ALK阳性非小细胞肺癌患者的一线治疗药物, objectType=article, longId=191689, objectId=a505191689b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a505191689b3, replyNumber=0, likeNumber=66, createdTime=2020-05-10, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a505191689b3, moduleTitle=欧盟批准武田的TKI抑制剂ALUNBRIG，用作ALK阳性非小细胞肺癌患者的一线治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a505191689b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990708, encodeId=62cc1990e0852, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, objectType=article, longId=190197, objectId=f41f19019e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f41f19019e2a, replyNumber=0, likeNumber=76, createdTime=2020-10-19, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f41f19019e2a, moduleTitle=林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f41f19019e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990732, encodeId=28b41990e32de, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Sci Rep：非小细胞肺癌患者使用术前营养控制状态评分（CONUT）预测术后肺部并发症, objectType=article, longId=198333, objectId=d5f41983336f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5f41983336f, replyNumber=0, likeNumber=88, createdTime=2020-11-10, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5f41983336f, moduleTitle=Sci Rep：非小细胞肺癌患者使用术前营养控制状态评分（CONUT）预测术后肺部并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5f41983336f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990719, encodeId=a8661990e1972, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet Oncol：肺癌患者生活质量评估更新版（QLQ-LC29）有效, objectType=article, longId=194333, objectId=97c61943336f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c61943336f, replyNumber=0, likeNumber=80, createdTime=2021-03-16, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c61943336f, moduleTitle=Lancet Oncol：肺癌患者生活质量评估更新版（QLQ-LC29）有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c61943336f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990701, encodeId=c0a81990e01e5, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=肺癌患者关爱活动“鼓5人生”音乐汇在上海成功举办, objectType=article, longId=183142, objectId=0db518314218, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0db518314218, replyNumber=0, likeNumber=71, createdTime=2019-12-01, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0db518314218, moduleTitle=肺癌患者关爱活动“鼓5人生”音乐汇在上海成功举办, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0db518314218)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990737, encodeId=3b8c1990e3726, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=NEJM：Selpercatinib用于RET融合阳性非小细胞肺癌患者的治疗, objectType=article, longId=199973, objectId=8ec51999e38c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ec51999e38c, replyNumber=0, likeNumber=62, createdTime=2021-01-26, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ec51999e38c, moduleTitle=NEJM：Selpercatinib用于RET融合阳性非小细胞肺癌患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ec51999e38c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990723, encodeId=586e1990e231a, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Chest：从不吸烟小细胞肺癌患者的临床和基因组学特征, objectType=article, longId=194754, objectId=5fc4194e5461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fc4194e5461, replyNumber=0, likeNumber=42, createdTime=2020-09-23, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fc4194e5461, moduleTitle=Chest：从不吸烟小细胞肺癌患者的临床和基因组学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fc4194e5461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990707, encodeId=2f111990e0784, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=战“疫”关键期，肺癌患者如何做到“治疗不中断，染病低风险”？, objectType=article, longId=189807, objectId=6ff218980e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ff218980e5a, replyNumber=0, likeNumber=68, createdTime=2020-10-16, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ff218980e5a, moduleTitle=战“疫”关键期，肺癌患者如何做到“治疗不中断，染病低风险”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ff218980e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990718, encodeId=28161990e18f0, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=ASCO 2020：罗氏的TIGIT单抗tiragolumab与PD-L1单抗Tecentriq联合，延长了非小细胞肺癌患者生存期, objectType=article, longId=194315, objectId=4a69194315ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a69194315ed, replyNumber=0, likeNumber=109, createdTime=2020-11-27, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a69194315ed, moduleTitle=ASCO 2020：罗氏的TIGIT单抗tiragolumab与PD-L1单抗Tecentriq联合，延长了非小细胞肺癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a69194315ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990699, encodeId=76a71990699e9, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=恩沙替尼治疗ALK阳性晚期非小细胞肺癌患者, objectType=article, longId=182449, objectId=a87318244947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a87318244947, replyNumber=0, likeNumber=89, createdTime=2020-06-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a87318244947, moduleTitle=恩沙替尼治疗ALK阳性晚期非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a87318244947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990733, encodeId=46531990e336b, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lung Cancer ：大规模的中DLL3流行病学研究发现，DLL3表达与小细胞肺癌患者预后无关, objectType=article, longId=198608, objectId=6b7919860879, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b7919860879, replyNumber=0, likeNumber=70, createdTime=2020-09-14, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b7919860879, moduleTitle=Lung Cancer ：大规模的中DLL3流行病学研究发现，DLL3表达与小细胞肺癌患者预后无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b7919860879)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990700, encodeId=07431990e006f, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=肺癌患者都需要基因检测吗？, objectType=article, longId=182654, objectId=e687182654e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e687182654e8, replyNumber=0, likeNumber=78, createdTime=2020-02-08, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e687182654e8, moduleTitle=肺癌患者都需要基因检测吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e687182654e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990721, encodeId=419f1990e2152, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=李峻岭教授：从临床实践到研究进展，全面基因组测序为晚期肺癌患者争取更多治疗机会, objectType=article, longId=194535, objectId=59e61945352c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59e61945352c, replyNumber=0, likeNumber=64, createdTime=2021-01-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59e61945352c, moduleTitle=李峻岭教授：从临床实践到研究进展，全面基因组测序为晚期肺癌患者争取更多治疗机会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59e61945352c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990698, encodeId=d2e2199069815, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=一线治疗显著改善广泛期小细胞肺癌患者的总生存期, objectType=article, longId=181036, objectId=bfa3181036ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfa3181036ef, replyNumber=0, likeNumber=128, createdTime=2020-03-28, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfa3181036ef, moduleTitle=一线治疗显著改善广泛期小细胞肺癌患者的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfa3181036ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990716, encodeId=25a51990e1649, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=CheckMate-227 三年随访数据证实：欧狄沃（纳武利尤单抗）联合伊匹木单抗为一线转移性非小细胞肺癌患者带来持久且长期的生存获益, objectType=article, longId=194156, objectId=071f1941562d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=071f1941562d, replyNumber=0, likeNumber=60, createdTime=2020-05-31, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=071f1941562d, moduleTitle=CheckMate-227 三年随访数据证实：欧狄沃（纳武利尤单抗）联合伊匹木单抗为一线转移性非小细胞肺癌患者带来持久且长期的生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=071f1941562d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990696, encodeId=9e071990696ab, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=百时美施贵宝公布欧狄沃®（nivolumab，纳武利尤单抗注射液）用于晚期经治非小细胞肺癌患者汇总五年总生存（OS）数据, objectType=article, longId=179251, objectId=fc171e9251bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc171e9251bb, replyNumber=0, likeNumber=71, createdTime=2020-01-24, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc171e9251bb, moduleTitle=百时美施贵宝公布欧狄沃®（nivolumab，纳武利尤单抗注射液）用于晚期经治非小细胞肺癌患者汇总五年总生存（OS）数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc171e9251bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990717, encodeId=d3b51990e1719, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=CheckMate -9LA临床试验数据积极！欧狄沃（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗显著提高一线转移性非小细胞肺癌患者总生存, objectType=article, longId=194157, objectId=c3b319415e0d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3b319415e0d, replyNumber=0, likeNumber=58, createdTime=2021-01-27, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3b319415e0d, moduleTitle=CheckMate -9LA临床试验数据积极！欧狄沃（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗显著提高一线转移性非小细胞肺癌患者总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3b319415e0d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990724, encodeId=49611990e24cd, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=又一适应症获批！欧狄沃®（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗用于转移或复发性非小细胞肺癌患者一线治疗, objectType=article, longId=194917, objectId=cfd319491ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfd319491ed0, replyNumber=0, likeNumber=69, createdTime=2020-12-26, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfd319491ed0, moduleTitle=又一适应症获批！欧狄沃®（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗用于转移或复发性非小细胞肺癌患者一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfd319491ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺癌患者

2020-05-29

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

J Clin Oncol：转移性鳞状非小细胞肺癌患者中使用卡铂-紫杉醇联合培博利珠单抗可改善患者的生活质量

2020-10-05

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Clini Cancer Res：SMARCA4突变可预测肺癌患者预后

2021-06-22

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

欧盟批准武田的TKI抑制剂ALUNBRIG，用作ALK阳性非小细胞肺癌患者的一线治疗药物

2020-05-10

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

林根教授谈新冠肺炎疫情逐步控制下肺癌患者的诊疗建议，推荐合适的患者接受口服抗肿瘤药物治疗

2020-10-19

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Sci Rep：非小细胞肺癌患者使用术前营养控制状态评分（CONUT）预测术后肺部并发症

2020-11-10

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet Oncol：肺癌患者生活质量评估更新版（QLQ-LC29）有效

2021-03-16

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

肺癌患者关爱活动“鼓5人生”音乐汇在上海成功举办

2019-12-01

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

NEJM：Selpercatinib用于RET融合阳性非小细胞肺癌患者的治疗

2021-01-26

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Chest：从不吸烟小细胞肺癌患者的临床和基因组学特征

2020-09-23

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

战“疫”关键期，肺癌患者如何做到“治疗不中断，染病低风险”？

2020-10-16

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

ASCO 2020：罗氏的TIGIT单抗tiragolumab与PD-L1单抗Tecentriq联合，延长了非小细胞肺癌患者生存期

2020-11-27

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

恩沙替尼治疗ALK阳性晚期非小细胞肺癌患者

2020-06-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lung Cancer ：大规模的中DLL3流行病学研究发现，DLL3表达与小细胞肺癌患者预后无关

2020-09-14

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

肺癌患者都需要基因检测吗？

2020-02-08

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

李峻岭教授：从临床实践到研究进展，全面基因组测序为晚期肺癌患者争取更多治疗机会

2021-01-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

一线治疗显著改善广泛期小细胞肺癌患者的总生存期

2020-03-28

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

CheckMate-227 三年随访数据证实：欧狄沃（纳武利尤单抗）联合伊匹木单抗为一线转移性非小细胞肺癌患者带来持久且长期的生存获益

2020-05-31

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

百时美施贵宝公布欧狄沃®（nivolumab，纳武利尤单抗注射液）用于晚期经治非小细胞肺癌患者汇总五年总生存（OS）数据

2020-01-24

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

CheckMate -9LA临床试验数据积极！欧狄沃（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗显著提高一线转移性非小细胞肺癌患者总生存

2021-01-27

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

又一适应症获批！欧狄沃®（纳武利尤单抗）联合伊匹木单抗及有限疗程化疗用于转移或复发性非小细胞肺癌患者一线治疗

2020-12-26

科室
- - 订阅+
  - 更多科室
工具
服务